Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fonds de la Recherche en Santé du Québec | OTHER_GOV |
| Fondation Antoine Turmel | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this trial is to determine the short-term effect of a self-care intervention on depression in patients with age-related macular degeneration or diabetic retinopathy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Self-Care Tools | Experimental | The tool binder includes 3 core tools and 4 supplemental tools. The tools that will be provided include a variety of self-care approaches to manage depression including audio-visual, internet, and paper-based tools that might appeal to individuals with different learning styles. The 3 core tools consist of the Antidepressant Skills Workbook, a Mood Monitoring Tool, and a DVD on depression. |
|
| Delayed Self-Care Tools | No Intervention | This group will receive the self-care tools at the conclusion of the study. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Self-Care Tools | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in depressive symptoms | Depressive symptoms will be measured by the PHQ-9, a validated 9 item instrument. | Baseline and 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in severity of anxiety symptoms | The GAD-7 can be used to establish probable diagnoses of generalized anxiety disorder as well as grade its severity (mild, moderate and severe). | Baseline and 8 weeks |
| Change in self-efficacy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ellen E. Freeman, PhD | Maisonneuve-Rosemont Hospital and University of Montreal | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Maisonneuve-Rosemont Hospital | Montreal | Quebec | H1T2M4 | Canada |
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| D008268 | Macular Degeneration |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D012162 | Retinal Degeneration |
| D012164 | Retinal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Self-efficacy will be measured with a 4-item scale, adapted from a validated diabetes self-care self-efficacy scale. Scores range from 0-12.
| Baseline and 8 weeks |
| Change in life space | The Life Space Assessment asks about the spatial extent in which the participant has traveled over the last month. Scores range from 0-100. | Baseline and 8 weeks |
| D005128 |
| Eye Diseases |